Pfizer and Allergan to combine in $160 billion deal
Deal shines more light on Ireland's 12.5 per cent corporate tax rate
Pfizer and Allergan agreed have agreed to merge in a record deal worth $160 billion (€150 billion) deal, which will create a drugmaking giant under the Pfizer name that will be based in Ireland for tax reasons.
Pfizer is the maker of erectile disfunction drug Viagra and cholesterol drug Lipitor, while Allergan makes the face-freezing wrinkle treatment Botox.
The deal has stirred controversy on both sides of the Atlantic because of the decision ...
